Gavin Rumbaugh

Exploring synaptic actin-myosin dynamics with super resolution microscopy

Control of synaptic circuits by small GTPase pathways

BioRaptr Replacement Dispensers to Support High Throughput Screening

Preclinical development of a precision therapy for a monogenic mental health disorder

Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma

Impact of autism genetic risk on cortical sensorimotor dynamics

Intersection of causal neurodevelopmental disorder risk genes, cortical circuit function, and cognitive processing required for behavioral adaptions

Neurodevelopmental Disorder Risk Gene Regulation of Intrinsic Membrane Excitability: A Rheostat that Tunes Dendritic Morphogenesis to Regulate Circuit Assembly During Development

Circuit-level substrates of ASD-related cognitive and behavioral impairments

Causal Interactions between genetic risk, precise cortical connectivity, and autismassociated behaviors

Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma

SYNGAP1 haploinsufficiency being linked to developmental epileptic encephalopathy and identification of a small molecule SYNGAP1 up-regulator

Integrated Platform for Discovery and Validation of Probes that Restore Protein Expression in Single-Gene Causes of Autism and Related Disorders

Myosin II regulation of actin dynamics and the selective vulnerability of methamphetamine- and opioid-associated memory

Molecular and cellular basis for autism spectrum disorders caused by exacerbated translation

Drug Discovery for First-in-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma

Human Neuron Dysfunction Associated with Presumed Disease-Causing SYNGAP1 Variants